Asia Pacific Antibody Discovery Market Forecast to 2030 - Regional Analysis - by Antibody Type (Monoclonal Antibodies, Polyclonal Antibodies, and Others), Nature (Human and Humanized, Chimeric, and Murine), Services (Phage Display, Hybridoma, Transgenic Animal, Single Cell, and Yeast Display), and End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, and Others)
The Asia Pacific antibody discovery market was valued at US$ 6,58,965.05 million in 2022 and is expected to reach US$ 11,58,681.86 million by 2030; it is estimated to register a CAGR of 7.3% from 2022 to 2030.
Proliferation of Biotechnology Industry in Developing Regions Boosts Asia Pacific Antibody Discovery Market
The remarkable precision of antibodies in identifying antigens makes them invaluable tools for scientists and clinicians. In modern biotechnology, antibodies are required in numerous processes, from basic research to innovative medical evaluations. The development of therapeutic antibodies has opened new avenues in treating various diseases, demonstrating the transformative ability of these particles. Antibodies are also crucial in antibody-based diagnostics as they provide accurate and reliable approaches to disease identification. Growing support from governments, rising public-private partnerships, continuously changing disease profiles, and increasing funding activities are widely enhancing the performance of biotechnology industries in the regions such as Asia Pacific.
As per the Organization for Economic Co-operation and Development (OECD), China was a frontrunner in terms of R&D expenditure as of 2019. Heavy investments encourage the adoption of advanced technologies in the healthcare sector. Governments of countries in regions such as Asia offer tax incentives, cheaper land, and direct investments for encouraging biotechnology companies to expand their capacities and strengthen their capabilities. Thus, countries such as Taiwan, Malaysia, India, China, Singapore, and Japan are among the most advantageous destinations for the biotechnology industries. Furthermore, these Asian countries are more focused on using genomics, proteomics, and biomarker advancements for diagnostic and therapeutic applications. Therefore, the ongoing proliferation of biotechnology industries in developing regions is expected to create opportunities for the antibody discovery market in the coming years.
Asia Pacific Antibody Discovery Market Overview
The Asia Pacific antibody discovery market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China accounted for the largest share of the market in 2022, and India is expected to record a significant CAGR in the market during the forecast period. The biopharmaceutical industry in China is undergoing a tremendous shift, evolving from a generics-focused landscape to a thriving innovation hub. Additionally, progress in industrialization, and the application of novel drugs, high-end medical devices, and techniques contribute to the antibody discovery market growth in China.
China is experiencing an upsurge in the prevalence of cardiovascular disease and other chronic diseases. According to the Journal of Biomedical and Environmental Science, nearly 330 million people from the country suffered from cardiovascular diseases in 2021. Antibody products are crucial for the development of novel therapeutics against cardiovascular diseases. Therefore, a burgeoning prevalence of heart disease triggers the need for antibody discovery. With the help of research centers, antibody sequences can be researched, new and novel antibodies can be developed, and existing antibodies can be optimized. According to the Scimago Institute Ranking, China had nearly 170 medical research centers as of 2022, followed by Japan (72), Australia (53), and India (17). Further, the growing number of market players focusing on countries in Asia Pacific for their geographic expansion and other growth strategies, the rising count of research centers, and a notable increase in government funding fuel the antibody discovery market growth in Asia Pacific.
Asia Pacific Antibody Discovery Market Revenue and Forecast to 2030 (US$ Billion)
Asia Pacific Antibody Discovery Market Segmentation
The Asia Pacific antibody discovery market is categorized into antibody type, nature, services, end user, and country.
Based on antibody type, the Asia Pacific antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held the largest Asia Pacific antibody discovery market share in 2022.
In terms of nature, the Asia Pacific antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held the largest Asia Pacific antibody discovery market share in 2022.
By services, the Asia Pacific antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held the largest Asia Pacific antibody discovery market share in 2022.
Based on end user, the Asia Pacific antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held the largest Asia Pacific antibody discovery market share in 2022.
Based on country, the Asia Pacific antibody discovery market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific antibody discovery market share in 2022.
Charles River Laboratories International Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, and Biocytogen Pharmaceuticals Beijing Co Ltd. are some of the leading companies operating in the Asia Pacific antibody discovery market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Antibody Discovery Market – Key Market Dynamics
4.1 Asia Pacific Antibody Discovery Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Investments in Research & Development
4.2.2 Rising Incidence of Cancer
4.3 Market Restraints
4.3.1 High Cost of Production
4.4 Market Opportunities
4.4.1 Proliferation of Biotechnology Industry in Developing Regions
4.5 Future Trends
4.5.1 Developments for Custom Antibodies
4.6 Impact of Drivers and Restraints:
5. Antibody Discovery Market – Asia Pacific Market Analysis
5.1 Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020–2030
6. Asia Pacific Antibody Discovery Market Analysis – by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Antibody Discovery Market Analysis – by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Antibody Discovery Market Analysis – by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Antibody Discovery Market Analysis – by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Antibody Discovery Market – Country Analysis
10.1 Asia Pacific Antibody Discovery Market, Revenue and Forecast to 2030
10.1.1 Asia Pacific: Antibody Discovery Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China
10.1.1.1.1 Overview
10.1.1.1.2 China: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 China: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 China: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 China: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 China: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Japan
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Japan: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Japan: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Japan: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Japan: Antibody Discovery Market Breakdown, by End User
10.1.1.3 India
10.1.1.3.1 Overview
10.1.1.3.2 India: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 India: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 India: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 India: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 India: Antibody Discovery Market Breakdown, by End User
10.1.1.4 Australia
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Australia: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.4.4 Australia: Antibody Discovery Market Breakdown, by Nature
10.1.1.4.5 Australia: Antibody Discovery Market Breakdown, by Services
10.1.1.4.6 Australia: Antibody Discovery Market Breakdown, by End User
10.1.1.5 South Korea
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 South Korea: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.5.4 South Korea: Antibody Discovery Market Breakdown, by Nature
10.1.1.5.5 South Korea: Antibody Discovery Market Breakdown, by Services
10.1.1.5.6 South Korea: Antibody Discovery Market Breakdown, by End User
10.1.1.6 Rest of Asia Pacific
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.6.4 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Nature
10.1.1.6.5 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Services
10.1.1.6.6 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 BioDuro LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Aragen Life Sciences Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Twist Bioscience Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Biocytogen Pharmaceuticals Beijing Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 4. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 5. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 6. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 7. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 8. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 9. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 10. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 11. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 12. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 13. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 14. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 15. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 16. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 17. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 18. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 19. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 20. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 21. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 22. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 23. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 24. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 25. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 26. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 29. Glossary of Terms, Antibody Discovery Market
List of Figures
Figure 1. Asia Pacific Antibody Discovery Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020 – 2030
Figure 4. Asia Pacific Antibody Discovery Market Share (%) – by Antibody Type (2022 and 2030)
Figure 5. Monoclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Polyclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific Antibody Discovery Market Share (%) – by Nature (2022 and 2030)
Figure 9. Human and Humanized: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Chimeric: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Murine: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Antibody Discovery Market Share (%) – by Services (2022 and 2030)
Figure 13. Phage Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hybridoma: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Transgenic Animal: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Yeast Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Single Cell: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Antibody Discovery Market Share (%) – by End User (2022 and 2030)
Figure 19. Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Research Laboratories: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific: Antibody Discovery Market, by Key Country – Revenue (2022) (US$ Million)
Figure 23. Asia Pacific: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 25. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 26. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 27. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in the Antibody Discovery Market
- Charles River Laboratories International Inc
- BioDuro LLC
- Sartorius AG
- Aragen Life Sciences Ltd
- Twist Bioscience Corp
- Biocytogen Pharmaceuticals Beijing Co Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific antibody discovery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific antibody discovery market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.